Neil Harris Cohen, Director at Chemomab Therapeutics Ltd. (CMMB), sold 2,409 shares at $2.00 ($5K) on 2022-11-16, disclosed to the SEC on 2022-11-18.
Open-market sale of $5k CMMB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CMMB | BUY | 2022-03-15 | $26K | — | Filing → |
| CMMB | BUY | 2021-12-08 | $15K | — | Filing → |
| CMMB | BUY | 2021-03-26 | $200K | — | Filing → |